赛莱拉品牌怎么样 申请店铺

广州赛莱拉干细胞科技股份有限公司（股票代码：831049），成立于2009年7月，是一家专注于干细胞研究、储存及应用的的国家高新技术企业。赛莱拉干细胞以“平台共享”创新商业模式，通过干细胞核心技术及HAI战略（Health大健康，Artificial Intelligence人工智能，Information Technology信息技术），满足人们对年轻、健康、美丽的需求，为全生命周期健康管理服务，打造干细胞全产业链世界级企业。

赛莱拉干细胞总部位于广州国际生物岛，承担建设全国最大的省级区域细胞制备中心，建设有世界一流水平的符合GMP标准的人类干细胞库，打造容纳一千万份细胞安全储存的“超级细胞工厂”，并拥有自主产权的干细胞科技园，国家发改委符合GMP要求的基因重组蛋白质类生物药中试公共服务平台、国家博士后科研工作站、国家院士工作站、省干细胞制备工程实验室等均落户在赛莱拉干细胞。公司于2014年8月登陆新三板，成为中国新三板首家干细胞挂牌企业。

赛莱拉干细胞在全国政协委员陈海佳总裁的领航下，组建了以苏国辉院士为首席科学家的全球高端人才科研团队，搭建产学研深度融合的创新体系，承担了50多个国家、省市重大科研项目。赛莱拉掌握干细胞核心技术，获得授权与受理发明专利达900多项，已连续三年干细胞专利申请位居中国第一，干细胞制备技术专利申请总量上位居全球第一，并拥有48个高新技术产品，荣膺“中国干细胞产业领军企业”、“中国新三板创新百强”、“中国最具影响力医药企业百强”。

Guangzhou selera Stem Cell Technology Co., Ltd. (Stock Code: 831049), founded in July 2009, is a national high-tech enterprise focusing on stem cell research, storage and application. Based on the "platform sharing" innovative business model, selera stem cells meet people's needs for youth, health and beauty through the core technology of stem cells and Hai strategy (health big health, artificial intelligence, information technology information technology), serve the whole life cycle health management, and build a world-class enterprise in the whole industry chain of stem cells. Selera stem cell is headquartered in Guangzhou International Biological Island, undertaking the construction of the largest provincial-level regional cell preparation center in China, building a world-class human stem cell bank in line with GMP standards, building a "super cell factory" that can hold 10 million cells for safe storage, and owning the independent property rights of stem cell science and technology park. The national development and Reform Commission meets the GMP requirements for gene recombinant eggs The public service platform for the pilot test of white matter biological drugs, the National Postdoctoral research workstation, the national academician workstation, and the provincial stem cell preparation engineering laboratory are all located in selera stem cells. The company landed on the new third board in August 2014 and became the first stem cell listed enterprise on the new third board in China. Under the guidance of Chen Haijia, chairman of the CPPCC National Committee, selera stem cell has established a global high-end talent research team with Academician Su Guohui as the chief scientist, built an innovation system of in-depth integration of production, learning and research, and undertaken major scientific research projects in more than 50 countries and provinces. Celela has mastered the core technology of stem cells, obtained more than 900 invention patents, and has ranked first in China for three consecutive years. The total number of patent applications for stem cell preparation technology ranks first in the world, and has 48 high-tech products. Celela has won the titles of "China's leading enterprise in stem cell industry", "China's top 100 new three board innovation" and "China's most influential enterprise" We will strive to become one of the top 100 pharmaceutical enterprises.

本文链接： https://brand.waitui.com/782a2d146.html 联系电话：37792600